IL11 and breast carcinoma: A role for IL-11 signaling in breast cancer has been less well-described, but elevated levels of IL-11 and IL-11Rα are associated with poor patient outcomes (223, 224) and both IL-11 and IL-6 are associated with breast cancer metastasis into bone (225).